Are you Dr. Carayannopoulos?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 66 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
660 S Euclid Ave
Saint Louis, MO 63110Phone+1 314-362-8983Fax+1 314-362-8987- Is this information wrong?
Summary
- Dr. Leonidas Carayannopoulos, MD is a pulmonologist in Saint Louis, Missouri. He is currently licensed to practice medicine in Missouri and New Jersey.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2003- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1996 - 1998
University of Texas Southwestern Medical SchoolClass of 1996
Certifications & Licensure
MO State Medical License 1998 - 2025
NJ State Medical License 2011 - 2025
Publications & Presentations
PubMed
- Assessment of CYP-Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients with Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic ...Yiming Cheng, Xiaomin Wang, Atalanta Ghosh, Jie Pu, Yan Li, Leonidas N Carayannopoulos> ;Journal of Clinical Pharmacology. 2024 Apr 2
- 1 citationsSafety, Pharmacokinetics, and Antifibrotic Activity of CC-90001 (BMS-986360), a c-Jun N-Terminal Kinase Inhibitor, in Pulmonary Fibrosis.Gerald Horan, Ying Ye, Mary Adams, Anastasia Parton, Dorota Cedzik, Shaojun Tang, Elizabeth A Brown, Liangang Liu, Jim Nissel, Leonidas N Carayannopoulos, Allison Gaud...> ;Clinical Pharmacology in Drug Development. 2023 Aug 1
- 2 citationsSafety, Pharmacokinetics, and Pharmacodynamics of CC-90001 (BMS-986360), a c-Jun N-terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.Ying Ye, Allison Gaudy, Michael Thomas, Josephine Reyes, Barbara Burkhardt, Gerald Horan, Liangang Liu, Jian Chen, Atalanta Ghosh, Leonidas N Carayannopoulos, Daniel A...> ;Clinical Pharmacology in Drug Development. 2022 Dec 1
- Join now to see all
Grant Support
- Molecular Physiology Of NKG2D Ligand ExpressionNational Institute Of Allergy And Infectious Diseases2004–2007
